Market closedNon-fractional
Amphastar Pharmaceuticals/AMPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Amphastar Pharmaceuticals
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Ticker
AMPH
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Rancho Cucamonga, United States
Employees
1,761
Website
www.amphastar.com
AMPH Metrics
BasicAdvanced
$2.1B
Market cap
14.50
P/E ratio
$2.91
EPS
0.85
Beta
-
Dividend rate
Price and volume
Market cap
$2.1B
Beta
0.85
Financial strength
Current ratio
2.175
Quick ratio
1.679
Long term debt to equity
92.621
Total debt to equity
93.271
Interest coverage (TTM)
5.98%
Management effectiveness
Return on assets (TTM)
11.26%
Return on equity (TTM)
25.34%
Valuation
Price to earnings (TTM)
14.503
Price to revenue (TTM)
3.011
Price to book
3.06
Price to tangible book (TTM)
31.46
Price to free cash flow (TTM)
12.652
Growth
Revenue change (TTM)
30.38%
Earnings per share change (TTM)
64.18%
3-year revenue growth (CAGR)
22.46%
3-year earnings per share growth (CAGR)
282.57%
What the Analysts think about AMPH
Analyst Ratings
Majority rating from 6 analysts.
AMPH Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$172M
-3.54%
Net income
$43M
19.39%
Profit margin
25.08%
23.79%
AMPH Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.65
$1.15
$0.88
$1.04
-
Expected
$0.56
$0.69
$0.93
$0.96
$0.80
Surprise
16.02%
65.53%
-4.93%
8.65%
-
AMPH News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Amphastar Pharmaceuticals stock?
Amphastar Pharmaceuticals (AMPH) has a market cap of $2.1B as of July 27, 2024.
What is the P/E ratio for Amphastar Pharmaceuticals stock?
The price to earnings (P/E) ratio for Amphastar Pharmaceuticals (AMPH) stock is 14.5 as of July 27, 2024.
Does Amphastar Pharmaceuticals stock pay dividends?
No, Amphastar Pharmaceuticals (AMPH) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Amphastar Pharmaceuticals dividend payment date?
Amphastar Pharmaceuticals (AMPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals (AMPH) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Amphastar Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.